Beijing Friendship Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1952-01-01

Employees: 1K

Market Cap: -

Website: https://www.bfh.com.cn

Clinical Trials

Incidence and Risk Factors of Parastomal Hernia in Patients With Permanent Colostomy in China

Conditions: Stoma Colostomy
Hernia

First Posted Date: 2021-09-29

Last Posted Date: 2021-09-29

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 712

Registration Number: NCT05061589

Locations: 🇨🇳
Beijing Friendship Hospital, Capital medical University, Beijing, Xicheng Dis, China
🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China

Extension Study of Carvedilol RCT Study

Not Applicable

Recruiting

Conditions: Liver Cirrhosis
Portal Hypertension

Interventions: Drug: Carvedilol 12.5 MG

First Posted Date: 2021-08-25

Last Posted Date: 2021-08-25

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 240

Registration Number: NCT05021406

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
Beijing Ditan Hospital, Capital Medical University, Beijing, Beijing, China

and more 11 locations

Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission

Not Applicable

Recruiting

Conditions: Complication of Bariatric Procedure
Type2 Diabetes

First Posted Date: 2021-08-20

Last Posted Date: 2022-08-03

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 248

Registration Number: NCT05015283

Locations: 🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China

The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal Cancer

Not yet recruiting

Conditions: Colorectal Cancer

First Posted Date: 2021-08-20

Last Posted Date: 2021-08-20

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 10000

Registration Number: NCT05015296

PSC Clinical Epidemiology in China

Active, not recruiting

Conditions: Primary Sclerosing Cholangitis

First Posted Date: 2021-07-29

Last Posted Date: 2023-05-26

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 800

Registration Number: NCT04981756

Locations: 🇨🇳
Beijing Youan Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
Shanghai Suvalue Health Scientific Ltd., Shanghai, Shanghai, China
🇨🇳
Beijing Friendship Hospital, Capital Medical Univeristy, Beijing, Beijing, China

PD-1 Antibody Improve Mixed Chimerism

Not Applicable

Conditions: PD-1 Antibody
Mixed Chimerism

Interventions: Drug: Toripalimab Injection

First Posted Date: 2021-06-29

Last Posted Date: 2021-06-29

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 20

Registration Number: NCT04944511

Locations: 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China

Neoadjuvant Chemoradiotherapy Plus Tislelizumab Followed by TME for LARC.

Phase 2

Recruiting

Conditions: Colorectal Neoplasms

Interventions: Combination Product: long course radiotherapy + capecitabine + PD-1 monoclonal antibody treatment combinations

First Posted Date: 2021-06-03

Last Posted Date: 2022-02-23

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 50

Registration Number: NCT04911517

Locations: 🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China

Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease

Phase 4

Recruiting

Conditions: Neurodegenerative Diseases
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Parkinson Disease
Movement Disorders

Interventions: Drug: Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules
Other: Placebo

First Posted Date: 2021-05-04

Last Posted Date: 2023-02-21

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 240

Registration Number: NCT04871464

Locations: 🇨🇳
China-Japan Friendship Hospital, Beijing, Beijing, China
🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China
🇨🇳
Jinan Central Hospital, Jinan, Shandong, China

and more 7 locations

A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy

Phase 2

Conditions: Unresectable Metastatic Colorectal Cancer

Interventions: Drug: fruquintinib plus capecitabine

First Posted Date: 2021-04-29

Last Posted Date: 2022-08-18

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 49

Registration Number: NCT04866108

Locations: 🇨🇳
Beijing Friendship Hospital, Beijing, China

Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases

Conditions: EBV Infection

First Posted Date: 2021-03-04

Last Posted Date: 2022-03-31

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 40

Registration Number: NCT04782674

Locations: 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy